Clinical Trial Update: Nivolumab and Plinabulin in Treating Patients With Stage IIIB-IV, Recurrent, or Metastatic Non-small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating nivolumab in combination with plinabulin for stage IIIB-IV, recurrent or metastatic non-small cell lung cancer; the study is terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Plinabulin (plinabulin)
• nivolumab (nivolumab)

Snippet

Sponsor: University of Washington | Conditions: ALK Gene Translocation, EGFR Activating Mutation | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2019-03-04